Fetal Monitoring Market
The global fetal monitoring market in terms of revenue was estimated to be worth $3.7 billion in 2023 and is poised to reach $5.2 billion by 2030, growing at a CAGR of 7.3% from 2023 to 2030.
A market industry trend analysis is included in the new research study. Industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and market purchasing behaviour are all included in the new study report. The major forces fueling the market's growth are advancements in foetal monitoring system technology and the growing number of obstetrics and gynaecology clinics.
Fetal Monitoring Market Dynamics
Driver: Preterm births are on the rise, as is the use of infertility therapy.
Preterm births are becoming increasingly prevalent as a result of variables such as high blood pressure, protracted pre-labor membrane rupture, antepartum haemorrhage, multiple gestations, assisted reproductive technologies, short cervixes, urinary tract infections (UTIs), and placenta previa, among others. As a result, advanced medical technologies in foetal monitoring systems have been implemented. According to the WHO, over 15 million preterm births occur each year, with approximately 1 million babies dying soon after birth, and serious neurological or physical disorders caused by preterm births are a big issue.
Opportunity: Non-invasive, portable, and more accurate foetal monitoring is being developed.
The market's top players are extending their product lines to provide portable and wireless monitoring systems that are accurate, safe, and cost-effective. For example, the Apogee 6 series of colour Doppler ultrasound imaging equipment will be released in November 2021 by the Shantou Institute of Ultrasonic Instruments Co., Ltd. (China). The Apogee 6200, Apogee 6300, and Apogee 6500 colour Doppler ultrasound systems are part of this series, and they may be used for cardiac, abdominal, vascular, musculoskeletal, urological, and OB/GYN clinical applications.
Restraint: There are refurbished products available.
The availability of reconditioned foetal monitoring systems is a key impediment to the market's expansion. CeviMed, SOMA TECH, Jaken Medical, and Absolute Medical Services all sell reconditioned foetal monitoring equipment. Various small and medium-sized hospitals use reconditioned equipment for cost-effectiveness, particularly in emerging nations with price-sensitive markets. As a result of these reasons, there is an increase in demand for refurbished foetal monitoring equipment, which is projected to continue in the next years, because all of these refurbished equipments provide the same functions as new equipment but at a reduced cost. This issue will reduce the income of firms in the market who sell branded foetal monitoring equipment.
Challenge: a scarcity of qualified healthcare providers
Recently, there has been a scarcity of experts who specialise in women's health and provide obstetrics, gynaecology, and other preventative and reproductive health care. The American College of Obstetricians and Gynaecologists (ACOG) predicts that demand for obstetrics and gynaecology experts would rise from 50,850 to 52,660 (4%) by 2030. This indicates that efforts in obstetrics and gynaecology may grow, with an emphasis on high-risk pregnancies, difficult gynaecological problems, and surgical treatments.
The market has a modest level of consolidation. In 2021, the top four companies in the market—GE Healthcare (US), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), FUJIFILM SonoSite, Inc. (US), and Cardinal Health, Inc. (US)—accounted for a combined 75% market share. There is fierce rivalry among market participants. Only large corporations can afford large capital investments as well as hefty R&D and manufacturing costs. This will keep new entrants out of the market.
By product, the ultrasound devices category accounted for the biggest proportion of the foetal monitoring market.
Ultrasound equipment, electronic maternal/fetal monitors, foetal electrodes, foetal doppler devices, uterine contraction monitors, telemetry devices, accessories & consumables, and other goods are the market segments. Because of the growing need for less invasive gynaecological therapies and the widespread use of ultrasound in obstetrics, ultrasonography accounts for the lion's share of this industry.
By mobility, the non-portable systems category accounted for the biggest proportion of the foetal monitoring market.
There are two types of systems on the market: non-portable systems and portable systems. The market is dominated by the non-portable system segment. The increased use of non-portable equipment in the sector's key end customers, hospitals and clinics, is driving it ahead.
By method, the non-invasive category held the biggest proportion of the foetal monitoring market.
The market has been divided into two categories: invasive and non-invasive. The non-invasive sector had the lion's share of the market. The rising number of high-risk pregnancies, together with continuous research and the introduction of new therapies, are driving market expansion.
By application, the antepartum category held the biggest proportion of the foetal monitoring market.
The market has been divided into two sections: antepartum and intrapartum. The antepartum sector accounted for the majority of market share. Antepartum is the longest gestation period for foetal surveillance to detect any foetal anomalies, propelling market growth.
By end user, hospitals held the highest proportion of the foetal monitoring market.
The market has been divided into three sections: hospitals, obstetrics and gynaecology clinics, and home care settings. The hospitals category accounted for the majority of market share. Rising government healthcare spending and the availability of high-end facilities are boosting market expansion.
North America is the largest market for fetal monitoring.
The worldwide market is divided into four regions: North America, Europe, Asia Pacific, and the Rest of the World. The largest geographical market for foetal monitoring was North America. The availability of specialists and Neonatal Intensive Care Units (NICUs) are two important drivers supporting the market's growth in North America. However, the Asia Pacific area provides high-growth potential for industry participants. During the projection period, this geographical sector is expected to have the greatest CAGR. Low-weight births and an increase in the number of married people, which would lead to an increase in the number of pregnancies, are factors driving market expansion in the region.
Some key players in the fetal monitoring market are:
- GE Healthcare (US)
- Siemens Healthineers (Germany)
- Koninklijke Philips N.V. (Netherlands)
- FUJIFILM SonoSite, Inc. (US)
- Cardinal Health, Inc. (US)
Fetal Monitoring Market Report Scope
This report categorizes the fetal monitoring market to forecast revenue and analyze trends in each of the following submarkets:
By Product
- Ultrasound Devices
- Electronic Maternal/Fetal Monitors
- Uterine Contraction Monitor
- 2D Ultrasound
- 3D/4D Ultrasound
- Doppler Imaging
- Fetal Electrodes
- Fetal Doppler Devices
- Telemetry Devices
- Accessories and Consumables
- Other Products
By Portability
- Portable systems
- Non-portable systems
By Method
- Invasive
- Non-Invasive
By Application
- Antepartum
- Intrapartum
By End User
- Hospitals
- Obstetrics and Gynecology Clinics
- Home Care Settings
By Region
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- Rest of the World
- Latin America
- Middle East &Afric
Recent Developments
- In May 2022, GE Healthcare (US) and Pulsenmore (Israel) agreed to expedite the adoption of Pulsenmore's home care ultrasound solutions and assist their aim of US FDA certification and commercial expansion.
- In April 2022, ArchiMed Group (France) bought Natus Medical Incorporated (US) in order to broaden the scope and breadth of Natus' market-leading products while focusing on R&D and exploring acquisitions of complementary firms.
- CONTEC Medical Systems Co., Ltd. (China) released the CMS1700B Colour Doppler Ultrasonic Diagnostic System in March 2021, which is used to diagnose problems in the abdomen, heart, peripheral vessels, breast, obstetrics and gynaecology, small organs, urology, muscle, incretion, paediatrics, and other areas.